MDSAP Explained: One Audit, Five Markets

The Medical Device Single Audit Program lets one quality system audit serve regulators in Australia, Brazil, Canada, Japan and the United States. How it works, and when it makes sense.

What MDSAP covers

MDSAP allows a recognised Auditing Organization to perform a regulatory audit of a manufacturer’s quality management system for participating authorities. The five core participating jurisdictions are Australia, Brazil, Canada, Japan and the United States.

Keep audit scope and market access separate

Confirm the manufacturer, facilities, activities and jurisdictions covered by the audit. An MDSAP audit is not a single product approval for all five markets. Each jurisdiction retains its own applicable product, establishment, local responsibility and post-market requirements.

Prepare and maintain the system

Plan the applicable quality-system processes, regulatory responsibilities, records, audit readiness, corrective action and continuing maintenance. Confirm the current programme requirements with a recognised Auditing Organization.

Official references

FDA — MDSAP roles and responsibilities ↗

FDA — Investigations Operations Manual, Chapter 5 ↗

Reviewed 21 November 2026. General information; product-specific and current requirements must be confirmed.

Share this insight:
LinkedIn
Facebook
X
WhatsApp
Pinterest
Email

On This Page

Need Regulatory Support?

Discuss Your Product With Our Team

Send us an overview of your product, existing registrations and intended markets.
Or call 400-0569-812
Keep Reading

More Regulatory Insights